Literature DB >> 15939968

Apathy and pituitary disease: it has nothing to do with depression.

Michael A Weitzner1, Steven Kanfer, Margaret Booth-Jones.   

Abstract

Increasingly, patients with pituitary disease are evaluated and treated at cancer centers. In many ways, these patients resemble patients with other malignant brain tumors. Although the majority of pituitary adenomas are benign, the physical, emotional, and cognitive changes that these patients experience on their well-being is malignant. Pituitary disease causes a variety of physical illnesses resulting from the alterations in the hypothalamic-pituitary-end organ axis. In addition, patients with pituitary diseases may experience many emotional problems, including depression, anxiety, behavioral disturbances, and personality changes, above and beyond the many reactions these patients may have to the myriad of adjustments that they must make in their lives. There is a growing understanding that pituitary patients may experience these emotional problems as a result of long-term effects that the pituitary tumor itself, treatment, and/or hormonal changes have on the hypothalamic-pituitary-end organ axis. The authors present a series of cases, in which patients with pituitary disease were diagnosed and treated for depression and showed little response to the treatment for depression. When the diagnosis of apathy syndrome was considered and treatment implemented, the patients' condition improved. A review of the literature on apathy, hypothalamic-pituitary-end organ axis dysfunction, and treatment for apathy syndrome is included.

Entities:  

Mesh:

Year:  2005        PMID: 15939968     DOI: 10.1176/jnp.17.2.159

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  8 in total

1.  Cognitive and perceptual disturbances in a young man.

Authors:  Janos Zahajszky; Davin K Quinn; Felicia A Smith; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  Work productivity and neuropsychological function in persons with skull base tumors.

Authors:  Bethany D Nugent; Jason Weimer; Chienwen J Choi; Cathy J Bradley; Catherine M Bender; Christopher M Ryan; Paul Gardner; Paula R Sherwood
Journal:  Neurooncol Pract       Date:  2014-09

Review 3.  Psychiatric aspects of brain tumors: A review.

Authors:  Subramoniam Madhusoodanan; Mark Bryan Ting; Tara Farah; Umran Ugur
Journal:  World J Psychiatry       Date:  2015-09-22

4.  Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma.

Authors:  Aylin Mehren; Jale Özyurt; Paula Zu Klampen; Svenja Boekhoff; Christiane M Thiel; Hermann L Müller
Journal:  J Neurooncol       Date:  2018-07-03       Impact factor: 4.130

5.  Apathy after hip fracture: a potential target for intervention to improve functional outcomes.

Authors:  Eric J Lenze; Michael C Munin; Mary Amanda Dew; Robert S Marin; Meryl A Butters; Elizabeth R Skidmore; Ellen M Whyte; Amy Begley; Charles F Reynolds
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 6.  The relationships between depression and brain tumors.

Authors:  N Scott Litofsky; Andrew G Resnick
Journal:  J Neurooncol       Date:  2009-03-05       Impact factor: 4.130

7.  Chronic Atypical Depression as an Early Feature of Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Filipa Cardoso; Heela Azizi; Alexander Kilpatrick; Olaniyi Olayinka; Tasmia Khan; Alexa Kahn; Cecilia Canale; Chiedozie Ojimba; Olusegun Popoola; Deepa Nuthalapati; Maleeha Ahmad; Mirna Iskander; Ali Chohan; Sara Parisi; Ulunma Umesi; Hashem Kalbouneh; Arka Bhattacharya; Kodjovi Kodjo; Oluwole Jegede; Ayodeji Jolayemi
Journal:  Case Rep Psychiatry       Date:  2019-07-21

8.  Assessment of clinicopathologic features in patients with pituitary adenomas in Northeast of Iran: A 13-year retrospective study.

Authors:  Kazem Anvari; Mahmoud Reza Kalantari; Fariborz Samini; Soodabeh Shahidsales; Mehdi Seilanian-Toussi; Zakiyeh Ghorbanpour
Journal:  Iran J Neurol       Date:  2015-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.